Mark J. Vignola - 30 Nov 2023 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Financial Officer
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Mark J. Vignola
Issuer symbol
TERN
Transactions as of
30 Nov 2023
Net transactions value
+$2,809
Form type
4
Filing time
04 Dec 2023, 18:03:23 UTC
Previous filing
02 Jun 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $2,809 +743 +4.2% $3.78 18,399 30 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 743 shares under the Terns Employee Stock Purchase Plan on November 30, 2023.

Remarks:

Voluntary reporting of ESPP purchase